CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Solid Tumour
Interventions: BIOLOGICAL: MVC-101|BIOLOGICAL: Nivolumab|COMBINATION_PRODUCT: MVC-101 + Nivolumab
Sponsor: Presage Biosciences
Collaborators: Takeda